What are the symptoms and treatment of tetanus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tetanus: Clinical Symptoms and Treatment

Primary Clinical Symptoms

Tetanus presents with characteristic muscle rigidity beginning in the jaw (trismus or "lockjaw") and progressing to generalized muscle spasms, with 75% of patients presenting with trismus as the initial symptom. 1, 2

Initial Presentation

  • Trismus (lockjaw) is the hallmark initial symptom, occurring in 75% of patients as the first manifestation 2
  • Muscle stiffness initially involves the jaw and neck, then becomes generalized 3
  • Dysphagia (difficulty swallowing) commonly accompanies early symptoms 4
  • The incubation period ranges from 3 to 21 days (median: 7 days), though extremes of 1 day to several months can occur 1

Disease Progression

  • Reflex spasms develop in 70% of patients and characterize disease severity 2
  • Tonic spasms of skeletal muscles are followed by paroxysmal contractions 3
  • Progressive descending paralysis can occur in severe cases requiring ventilatory support 5
  • Shorter incubation periods correlate with more severe disease and poorer prognosis 1

Critical Complications

  • Respiratory failure from respiratory muscle involvement occurs early and requires aggressive airway management 2
  • Autonomic instability (sympathetic nervous system overactivity) typically develops during the second and third weeks 5
  • Cardiovascular instability is among the most common complications 5

Treatment Algorithm

Immediate Interventions (First 24 Hours)

Treatment must focus on four simultaneous goals: neutralizing unbound toxin, eliminating the organism, controlling muscle spasms, and providing intensive supportive care. 3, 2

1. Toxin Neutralization

  • Administer tetanus immunoglobulin (TIG) 5000 units intramuscularly immediately to neutralize circulating toxin before it binds irreversibly to neural tissue 5, 6
  • Give tetanus toxoid 0.5 mL intramuscularly at a different site 5
  • This must be done urgently because tetanospasmin binds irreversibly with neural tissue, making early neutralization critical 6

2. Antibiotic Therapy

  • Administer procaine penicillin G or metronidazole to eliminate Clostridium tetani and interrupt toxin production 4, 3
  • Erythromycin is an alternative for penicillin-allergic patients 5

3. Muscle Spasm Control

  • Diazepam is the first-line agent for controlling rigidity and spasms in all cases 4, 2, 5
  • Mild cases may be managed with diazepam alone 2
  • Severe cases require addition of nondepolarizing neuromuscular blocking agents (e.g., pancuronium bromide) plus mechanical ventilation 2, 5
  • Adjunctive agents include chlorpromazine and morphine for sedation, muscle relaxation, and analgesia 5

Supportive Care Requirements

Environmental Management

  • Place patient in a semidark, quiet room to minimize stimuli that trigger reflex spasms 5
  • Isolation unit placement is recommended 4

Intensive Monitoring and Support

  • The disease course is usually intense for ≥4 weeks before subsiding, requiring prolonged intensive care 1
  • Ventilatory support is essential for patients with respiratory muscle involvement 2, 5
  • Ranitidine for stress ulcer prophylaxis 5
  • Heparin for deep-vein thrombosis prevention 5
  • Nutritional support (peripheral-vein or enteral nutrition) 5

Autonomic Dysfunction Management

  • Monitor for sympathetic nervous system overactivity during weeks 2-3 5
  • Treat with alpha and beta blockade when autonomic instability occurs 2

Wound Management

  • Debride necrotic tissue to eliminate anaerobic conditions that allow C. tetani germination 6, 3
  • Appropriate wound care is essential for both treatment and prevention 3

Critical Prognostic Factors

Mortality Risk

  • Without high-quality medical care, mortality approaches 100% 1, 6
  • With modern intensive care, case-fatality rates range from 10-20% (most recent U.S. data shows 8.0% for 2001-2016) 1, 7
  • Highest mortality occurs in infants and elderly patients 1, 6
  • Shorter incubation periods predict worse outcomes 1

Long-Term Sequelae

  • The convalescent period is protracted 1
  • Long-term neurologic sequelae and intellectual/behavioral abnormalities may follow recovery 1

Post-Recovery Immunization

Tetanus does not confer natural immunity, so patients must complete a full primary immunization series after recovery 1. This is a critical pitfall—surviving tetanus does not protect against future infection because naturally acquired immunity does not occur 8.

Prevention Context

  • Tetanus occurs almost exclusively among unvaccinated or inadequately vaccinated persons 8, 1
  • A completed primary vaccination series substantially reduces disease risk, and protection lasts at least 10 years 8
  • High mortality rates may result from delays in diagnosis and lack of familiarity with treatment 2

References

Guideline

Tetanus Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tetanus: a review.

Critical care medicine, 1979

Research

Current concepts in the management of Clostridium tetani infection.

Expert review of anti-infective therapy, 2008

Research

A case report of generalized tetanus in a 42-year-old man with dental infection.

Journal of basic and clinical physiology and pharmacology, 2019

Research

Management of tetanus.

Clinical pharmacy, 1987

Guideline

Pathophysiology and Clinical Manifestations of Tetanus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tetanus Survival Rate and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.